I

Integer Holdings Corporation

Medical device CDMO for cardiac devices

Manager – Operations

Full-TimeUpdated on 10/23/2026
No salary listed
Expert
Trenton, GA, USA
In Person
Manufacturing & Production Operations

About the job

Requirements
  • Adhere to Integer’s Values, company policies, procedures, and work instructions defined in the training plan.
  • Ensure compliance with the established Quality Management System and Environmental, Health, Safety, and Security protocols.
  • Meet customer requirements for production performance standards, including required change management and customer notifications.
Responsibilities
  • Assume responsibility for production activities associated with assigned product lines at a manufacturing site and deliver the established key performance goals and targets.
  • Represent the Operations Team, contribute to annual Operations goals and objectives, and represent the team to the Site Leadership Team as needed.
  • Lead direct reports, including Production Supervisors and individual performers.
  • Lead the execution of manufacturing-related imperatives in the site Hoshin Plan.
  • Develop and execute sustained continuous improvement processes.
  • Define goals, objectives, and supporting key performance indicators for direct reports across safety, quality, delivery, inventory, and productivity.
  • Develop individual growth and development plans and organizational succession plans.
  • Observe production operations on the floor, ask questions, and listen to associates.
  • Communicate with associates through daily production boards, weekly project update meetings, monthly KPI Board reviews, and Town Hall meetings.
  • Engage with associates across levels and functions, including through regular informal interactions and diagonal-slice meetings.
  • Meet regularly one-on-one with direct reports to monitor performance and progress on individual development plans.
  • Interact with internal and external customers, support customer business review preparations, and participate in customer or other-party site visits and audits as needed.
  • Partner with Operations peers to align strategies, tactics, and actions for achieving operational objectives.
  • Collaborate with Research and Development and Product Development teams to prioritize Operations resources and support new product launches.
  • Embed quality within the Operations team by ensuring QMS adherence, facilitating corrective and preventive actions, and contributing to quality key performance indicators and the 5 Sigma objective.
  • Perform other duties as needed and as directed.
  • Champion deployment of systems and tools that optimize production activities across the site.
  • Support Manufacturing Excellence through Strategy Alignment, Leadership of Sustained Change, Standardization, Associate Engagement, and Systems and Process Optimization.
  • Use Site Hoshin Plans, regular Sales, Inventory, and Operations Planning meetings, and value stream map updates to support strategy alignment.
  • Ensure production monitoring and improvement activities and deployment of Leader Standard Work to sustain change.
  • Support standardization through workplace organization and visual controls (5S), Manufacturing Standard Work, and training and certification programs.
  • Promote associate engagement through standardized problem-solving methods, behavior-based safety programs, and improvement idea and suggestion systems.
  • Optimize systems and processes through built-in quality, scheduling and material-system designs, work-cell design, and total productive maintenance.
  • Participate in developing and vetting production plans with Production, Planning, Continuous Improvement, Customer Service, Quality, and Materials representatives.
  • Monitor actual daily and longer-term performance against the production plan and drive actions to address off-standard performance.
  • Achieve safety, people, quality, delivery, inventory, productivity, and cost-improvement performance measures, including applicable observations, engagement and turnover measures, customer complaints, nonconformance and corrective-action cycle times, supplier performance, delivery and schedule attainment, inventory turns, yield, labor efficiency, equipment effectiveness, throughput, downtime, and recognized savings.

About the company

I

Integer Holdings Corporation

View

Integer Holdings Corporation is a large medical device contract development and manufacturing organization (CDMO) that supports medical device makers in cardiac rhythm management, neuromodulation, and cardiovascular markets. It provides end-to-end services from design support to manufacturing, delivering components and finished subsystems such as implants, housings, electrodes, and batteries through its Greatbatch Medical, Lake Region Medical, and Electrochem brands. The company differentiates itself by its scale, breadth of capabilities across multiple medical specialties, established brand portfolio, and global manufacturing footprint that enable reliable, integrated supply. Its goal is to improve patients’ lives worldwide by helping customers bring safe and effective medical technologies to market.

Company Size

1,001-5,000

Company Stage

IPO

Headquarters

Wilmington, Delaware

Founded

1940

Get referred to Integer Holdings Corporation

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Q2 2026 revenue hit $464.1 million, beating estimates despite weak medtech demand.
  • Integer expects demand recovery after New Ross's July 27-August 10, 2026 shutdown.
  • KKR plans new capacity, technology, and employee ownership after closing by year-end 2026.

What critics are saying

  • Integer withdrew 2026 guidance on August 3, 2026, after KKR announced the buyout.
  • Schall, Brown & Schwartz opened an August 23, 2026 fiduciary-duty investigation.
  • Regulatory or stockholder rejection kills the KKR deal and leaves Integer's weak standalone outlook exposed.

What makes Integer Holdings Corporation unique

  • Integer's R&D Velocity integrates design, prototyping, and manufacturing for complex medtech programs.
  • Its 33-facility global network spans electrophysiology, neuromodulation, and structural heart.
  • KKR's August 3, 2026, $5.7 billion bid validates Integer's scale and customer lock-in.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Health Insurance
  • Dental Insurance
  • Vision Insurance
  • Life Insurance
  • Disability Insurance
  • Adoption Assistance
  • Parental Leave
  • 401(k) Company Match
  • 401(k) Retirement Plan
  • Paid Vacation
  • Paid Holidays

Growth & Insights and Company News

6 month growth

1%

1 year growth

0%

2 year growth

0%
Ticker Report
Aug 29th, 2026
Boussard & Gavaudan Gestion Sas Makes New $2.60 Million Investment in Integer Holdings Corporation $ITGR

Boussard & Gavaudan Gestion Sas bought a new position in Integer Holdings Corporation (NYSE:ITGR – Free Report) during the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The firm bought 28,153 shares of the medical equipment provider’s stock, valued at approximately $2,597,000. Other institutional investors and hedge funds also […]

Yahoo Finance
Aug 16th, 2026
Healthcare stocks outpace S&P 500 by 13 percentage points over six months

Healthcare stocks have returned 26.1% over the past six months, outperforming the S&P 500 by 13.1 percentage points. However, investors must remain cautious due to heavy regulation affecting earnings potential. Integer Holdings faces concerns with 6.1% annual revenue growth over two years, lagging healthcare peers. Its modest revenue base of $1.84 billion provides less fixed cost leverage than larger competitors. The company trades at $125.07 per share, or 18.6 times forward price-to-earnings. Evolent Health shows weak platform performance and declining returns on capital. Its high net-debt-to-EBITDA ratio of 7 times could force unfavourable capital raises if market conditions worsen. Shares trade at $4.15, representing 12.4 times forward price-to-earnings. Tenet Healthcare, operating hospitals and surgical centres across nine US states, emerges as the recommended healthcare investment.

Yahoo Finance
Aug 4th, 2026
Integer Holdings acquired by KKR for $5.7B in all-cash deal at $127 per share

Integer Holdings agreed to be acquired by private equity firm KKR in an all-cash deal valued at approximately $5.7 billion. The transaction values the medical technology company at $127 per share. Shares jumped 2.7% in afternoon trading, continuing a rally from the previous session when the stock surged over 20% following the announcement. The acquisition news overshadowed strong second-quarter results, where Integer posted an adjusted profit of $1.60 per share on $464.1 million in revenue, surpassing analyst estimates. Following the buyout announcement, Integer withdrew its previously issued financial guidance and cancelled its upcoming earnings conference call. Shares traded at $124.50, marking a new 52-week high.

BizWire Express
Aug 3rd, 2026
KKR to acquire Integer for $5.7B in all-cash deal at $127 per share

KKR has agreed to acquire Integer Holdings Corporation, a medical device contract development and manufacturing organisation, in an all-cash transaction valued at approximately $5.7 billion. Integer stockholders will receive $127 per share, representing a 51.8% premium to the company's closing share price on 29 April 2026. The acquisition follows a comprehensive strategic review announced by Integer in April 2026. The Integer Board unanimously approved the agreement and recommends stockholder approval. KKR plans to invest in Integer's capacity, technology, innovation, and talent. The firm also intends to establish a broad-based employee ownership programme following the transaction's close, consistent with its approach across portfolio companies. The transaction is expected to close by year-end, subject to stockholder approval and regulatory clearances. Upon completion, Integer will become privately held and delist from the New York Stock Exchange.

Yahoo Finance
Aug 3rd, 2026
Integer Holdings beats Q2 expectations with $464M revenue and $1.60 earnings per share

Integer Holdings Corp. reported second-quarter net income of $23.6 million, or 69 cents per share. Adjusted earnings came to $1.60 per share, exceeding Wall Street expectations of $1.38 per share. The Plano, Texas-based medical device outsource manufacturer posted revenue of $464.1 million for the period, also beating analyst forecasts of $452.5 million. The results surpassed predictions from five analysts surveyed by Zacks Investment Research on both earnings and revenue metrics.